Insider trade

Century Therapeutics (IPSC): SVP Finance & Operations sold ~$158

Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold ~$158 of Century Therapeutics shares.

~$158
Approx. value · 296 sh @ $0.534
406K
Holds after · shares reported
Traded
Aug 4, 2025
Filed
Aug 6, 2025

What stands out in this filing

  • The sale was 0.1% of the shares this insider held before it; the filing reports 405,686 shares afterwards.
  • 296 shares at an average of $0.534 each, as reported on the form.
  • Footnote references tax withholding.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 9, 2025Insider · 4 peopleInsiders: 4 sales (~$4K)
  2. Aug 4, 2025 · this disclosureInsiderOfficer sold ~$158 of IPSC shares in the open market

What came next

  1. Sep 8, 2025Insider · 3 peopleInsiders: 3 sales (~$645)
  2. Nov 3, 2025InsiderOfficer sold ~$171 of IPSC shares in the open market
  3. Nov 13, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  4. Nov 17, 2025InsiderCEO sold ~$15K of IPSC shares in the open market
  5. Nov 19, 2025Insider · First insider buy since Sep 2024CEO purchased ~$17K of IPSC shares in the open market
  6. Nov 20, 2025InsiderOfficer sold ~$2.7K of IPSC shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Century Therapeutics

For Century Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IPSC page.

Other recent filings by Douglas Carr, SVP Finance & Operations

The full history of Douglas Carr, SVP Finance & Operations is on the profile page.

How this filing works

Explore the data

Common questions

Which Century Therapeutics (IPSC) insider traded, and how much?

Douglas Carr, SVP Finance & Operations at Century Therapeutics, sold ~$158 of Century Therapeutics shares. 296 shares at $0.53.

When did it happen, and when was it made public?

Traded: Aug 4, 2025. Filed: Aug 6, 2025. That is 2 days between the two dates.

What stands out in this filing?

The sale was 0.1% of the shares this insider held before it; the filing reports 405,686 shares afterwards. 296 shares at an average of $0.534 each, as reported on the form. Footnote references tax withholding.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Century Therapeutics recently?

For Century Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the IPSC page.

Does this mean IPSC stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Century Therapeutics

Everything OQRO holds on this company is on its IPSC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data